Other OTC - Delayed Quote USD

Aspen Pharmacare Holdings Limited (APNHF)

9.20 0.00 (0.00%)
At close: September 22 at 1:43 PM EDT
Currency in ZAR All numbers in thousands
Download
Breakdown
TTM
6/30/2023
6/30/2022
6/30/2021
6/30/2020
Total Revenue
40,709,000.00
40,709,000.00
38,606,000.00
37,766,000.00
33,659,000.00
Cost of Revenue
22,301,000.00
22,301,000.00
20,300,000.00
19,977,000.00
16,524,000.00
Gross Profit
18,408,000.00
18,408,000.00
18,306,000.00
17,789,000.00
17,135,000.00
Operating Expense
9,465,000.00
9,465,000.00
9,515,000.00
9,664,000.00
9,030,000.00
Operating Income
8,943,000.00
8,943,000.00
8,791,000.00
8,125,000.00
8,105,000.00
Net Non Operating Interest Income Expense
-815,000.00
-815,000.00
-673,000.00
-1,097,000.00
-1,511,000.00
Pretax Income
6,555,000.00
6,555,000.00
8,134,000.00
5,989,000.00
4,198,000.00
Tax Provision
1,327,000.00
1,327,000.00
1,646,000.00
1,191,000.00
818,000.00
Net Income Common Stockholders
5,228,000.00
5,228,000.00
6,488,000.00
4,806,000.00
4,664,000.00
Diluted NI Available to Com Stockholders
5,228,000.00
5,228,000.00
6,488,000.00
4,806,000.00
4,664,000.00
Basic EPS
11.77
--
14.32
10.53
10.22
Diluted EPS
11.77
--
14.32
10.53
10.22
Basic Average Shares
444,200.00
--
453,000.00
456,500.00
456,500.00
Diluted Average Shares
444,200.00
--
453,000.00
456,500.00
456,500.00
Total Operating Income as Reported
7,822,000.00
7,822,000.00
8,671,000.00
7,072,000.00
5,730,000.00
Rent Expense Supplemental
--
--
50,000.00
84,000.00
21,000.00
Total Expenses
31,766,000.00
31,766,000.00
29,815,000.00
29,641,000.00
25,554,000.00
Net Income from Continuing & Discontinued Operation
5,228,000.00
5,228,000.00
6,488,000.00
4,806,000.00
4,664,000.00
Normalized Income
5,950,190.00
5,950,190.00
6,524,708.00
5,600,602.00
4,907,890.00
Interest Income
509,000.00
509,000.00
92,000.00
108,000.00
141,000.00
Interest Expense
1,324,000.00
1,324,000.00
765,000.00
1,205,000.00
1,652,000.00
Net Interest Income
-815,000.00
-815,000.00
-673,000.00
-1,097,000.00
-1,511,000.00
EBIT
7,879,000.00
7,879,000.00
8,899,000.00
7,194,000.00
5,850,000.00
EBITDA
9,667,000.00
9,667,000.00
10,612,000.00
8,847,000.00
7,453,000.00
Reconciled Cost of Revenue
22,301,000.00
22,301,000.00
20,300,000.00
19,977,000.00
16,524,000.00
Reconciled Depreciation
1,788,000.00
1,788,000.00
1,713,000.00
1,653,000.00
1,603,000.00
Net Income from Continuing Operation Net Minority Interest
5,228,000.00
5,228,000.00
6,488,000.00
4,798,000.00
3,380,000.00
Total Unusual Items Excluding Goodwill
-905,000.00
-905,000.00
-46,000.00
-1,002,000.00
-1,898,000.00
Total Unusual Items
-905,000.00
-905,000.00
-46,000.00
-1,002,000.00
-1,898,000.00
Normalized EBITDA
10,572,000.00
10,572,000.00
10,658,000.00
9,849,000.00
9,351,000.00
Tax Rate for Calcs
0.00
0.00
0.00
0.00
0.00
Tax Effect of Unusual Items
-182,810.00
-182,810.00
-9,292.00
-199,398.00
-370,110.00
6/30/2020 - 4/29/2010

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade